Hebei Lansheng Biotech Co., Ltd.
Beijing Multigrass Formulation Co., Ltd.

BASF and Monsanto soybean seed treatment dealqrcode

Jul. 2, 2008

Favorites Print
Jul. 2, 2008
BASF and Monsanto have signed an exclusive agreement for a new fungicide seed treatment solution for soybeans in the United States. The new product contains BASF’s fungicidal seed treatment, F500 (pyraclostrobin), and is expected to be commercialised in conjunction with the launch of Monsanto’s second generation genetically modified glyphosate -tolerant Roundup Ready 2 Yield soybean next year. Under the agreement, Monsanto will have exclusive rights to market the new fungicide seed treatment in soybeans.
BASF says that the seed treatment, apart from providing disease protection, results in improved stand and extra vitality for the plant. “The product would be especially significant for Monsanto because of the added-value like enhanced seed vitality that one gets from the F500 seed treatment”, says BASF’s director of seed treatment and global strategic marketing, Hans-Jurgen Lutz. The company received US approval for its pyraclostrobin-based fungicidal seed treatment, Stamina in February.
Roundup Ready 2 Yield soybeans are a higher yielding version of Monsanto’s original Roundup Ready soybeans, and received commercial approval in the US and Canada in 2007  and in Japan, the Philippines and Taiwan earlier this year. The company plans its controlled commercial release on 1-2 million acres (400,000-800,000 ha) in 2009, with a full-scale launch on 5-6 million acres in 2010. “We feel the product will be the best seed treatment fungicide available to complement our new Roundup Ready 2 Yield soybean offering,” said Monsanto’s executive vice president, Carl Casale.
Monsanto treats more than 1,000 million lbs (453,600 tonnes) of seed each year and plans to establish a global seed treatment business to complement its seed and trait operation. The company has revealed plans to apply a proprietary seed treatment to all of its Roundup Ready 2 Yield soybeans. In April, it entered into an agreement with Bayer CropScience for a fungicidal seed treatment for maize. The deal concerned Bayers Vortex (ipconazole), which is expected to be commercialised in conjunction with the planned launch of Monsantos multiple insect-resistant SmartStax maize in 2010 in the US.
BASF and Monsanto entered a deal in 2007 to co-promote BASFs pyraclostrobin fungicide Headline in the US for use on Monsanto’s glyphosate-tolerant Roundup Ready maize. BASF says that the agreement “is expected to show promising results in the first year of co-promotion”.
Source: AgroNews

Picture 0/1200

More from AgroNews


2020 Biologicals Special 2020 Latin America Focus
2020 Formulation & Adjuvant Technology Annual Review 2019
Chinese issue of Annual Review 2019 2019 CRO & CRAO Manual
Subscribe Comment


Subscribe Email: *
Mobile Number:  


Picture 0/1200

Subscribe to daily email alerts of AgroNews.